Ricerca Progetti finanziati

Progetti finanziati

• Amedeo Amedei: MICAFRICA “Towards a North-African Consortium of the Human Microbiome (NACHM) through strengthening the Capacities in Microbiome Analysis for Human Diseases at University of Sfax”;
• Francesco Annunziato: PRIN 2017 “Cell Plasticity of tumor – Associated immune infiltrate: molecular mechanism and therapeutic options”;
• Francesco Annunziato: FISM18: Meccanismi molecolari che regolano la proliferazione e la plasticità dei linfociti T helper 17: implicazioni per la patogenesi e la progressione della sclerosi multipla;
• Francesco Annunziato: REPAIR “RESTORING CARDIAC MECHANICAL FUNCTION BY POLYMERICARTIFICIAL MUSCULAR TISSUE”;
• Annarosa Arcangeli: PHIONIC “pH and Ion Transport in Pancreatic Cancer”;
• Annarosa Arcangeli: Progetto AIRC 2018 “Targeting the tumour antigen "hERG1/Beta1 integrin" to control cancer metastasis”;
• Annarosa Arcangeli: PRIN 2017 “Leveraging basic knowledge of ion channel network in cancer for innovative therapeutic strategies”;
• Arcangeli Giulio: Progetto BRIC 2020 “Aspetti innovativi connessi alla prevenzione del rischio da rumore e vibrazioni: sviluppo di dispositivi basati sulla tecnologia Active Noise Control e Active Vibration Control per la protezione dei lavoratori [...];
• Baldi Elisabetta: PRIN 2017 “Multilevel machine learning of toxicogenomic, molecular, endocrine, genotoxic and transgenerational effects of air pollution on reproduction”;
• Carloni Vinicio: PRIN 2017 “Novel molecular players of hypoxia/inflammation impinging on lipid homeostasis in obesity and relate”;
• Cecchi Francesca: VIRTREAD-PD “Biomarcatori dell’outcome riabilitativo in pazienti con Malattia di Parkinson: valutazione dell’efficacia di un percorso riabilitativo con realtà virtuale aumentata e customizzazione del trattamento - studio RCT con follow-up a 3 mesi”
• D’Elios Mario Milco: SVATT “Sviluppo e validazione pre-clinica di un trattamento TERANOSTICO per il tumore del melanoma basato sull’impiego di cellule del sistema immunitario, T Cells, rinforzate tramite loading con nanoparticelle magnetiche che consentano il delivering di farmaci specifici, l’applicazione di ipertermia localizzata, e una diagnostica MRI avanzata”;
• Di Bari Mauro: SPRINTT “Sarcopenia and Physical fRailty IN older people: multi‐componenT Treatment strategies”;
• Di Bari Mauro: HAI COVID “Infezioni correlate all’assistenza e diffusione del COVID-19 nei servizi sanitari della Toscana”;
•  Maggi Laura: PRIN 17 “Emerging players shaping the responses of tumor inflammatory infiltrate”;
• Rossolini Gian Maria: LIGHT4LUNGS “Inhalable Aerosol Light Source for Controlling Drug- Resistant Bacterial Lung Infections”;
• Rossolini Gian Maria: PRIN 2017 “Next – generation antibacterials: new targets for old drugs and new drugs for old target”;
• Santini Valeria: INTERCEPT “Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells”;
• Torcia Maria: VAMP “Role of vaginal microbiota in Human Papilloma Virus clearance and persistance”;
• Vannucchi Alessandro: MYNERVA “Metastatic disease: the key unmet need in oncology”;
• Vannucchi Alessandro: ACCELERATOR “Early detection and intervention: Understanding the mechanisms of transformation and hidden resistance of incurable haematological malignancies”;
• Vannucchi Alessandro: PRIN 2017 “Myeloid Neoplasm: an integrated clinical, molecular and therapeutic approach”;
• Vannucchi Maria: PROPREBIOAD “The role of the gut microbiota in Alzheimer’s disease pathogenesis. Prebiotic and probiotic treatments could prevent or reduce the Aß deposition in the gut and brain. A pre-clinical study in a mouse animal model".